BCR-ABL and V-SRC Tyrosine Kinase Oncoproteins Support Normal Erythroid Development in Erythropoietin Receptor-deficient Progenitor Cells

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1999 Nov 11

PMID 10557295

Citations 7

Authors

S Ghaffari

H Wu

M Gerlach

Y Han

H F Lodish

G Q Daley

Affiliations

Soon will be listed here.

Abstract

Erythropoietin (Epo)-independent differentiation of erythroid progenitors is a major characteristic of myeloproliferative disorders, including chronic myeloid leukemia. Epo receptor (EpoR) signaling is crucial for normal erythroid development, as evidenced by the properties of Epo(-/-) and EpoR(-/-) mice, which contain a normal number of fetal liver erythroid progenitors but die in utero from a severe anemia attributable to the absence of red cell maturation. Here we show that two constitutively active cytoplasmic protein tyrosine kinases, P210(BCR-ABL) and v-SRC, can functionally replace the EpoR and support full proliferation, differentiation, and maturation of fetal liver erythroid progenitors from EpoR(-/-) mice. These protein tyrosine kinases can also partially complement the myeloid growth factors IL-3, IL-6, and Steel factor, which are normally required in addition to Epo for erythroid development. Additionally, BCR-ABL mutants that lack residues necessary for transformation of fibroblasts or bone marrow cells can fully support normal erythroid development. These results demonstrate that activated tyrosine kinase oncoproteins implicated in tumorigenesis and human leukemia can functionally complement for cytokine receptor signaling pathways to support normal erythropoiesis in EpoR-deficient cells. Moreover, terminal differentiation of erythroid cells requires generic signals provided by activated protein tyrosine kinases and does not require a specific signal unique to a cytokine receptor.

Citing Articles

Gene Expression Differences between Enriched Normal and Chronic Myelogenous Leukemia Quiescent Stem/Progenitor Cells and Correlations with Biological Abnormalities.

Affer M, Dao S, Liu C, Olshen A, Mo Q, Viale A J Oncol. 2011; 2011:798592.

PMID: 21436996 PMC: 3062978. DOI: 10.1155/2011/798592.

C/EBPalpha determines hematopoietic cell fate in multipotential progenitor cells by inhibiting erythroid differentiation and inducing myeloid differentiation.

Suh H, Gooya J, Renn K, Friedman A, Johnson P, Keller J Blood. 2006; 107(11):4308-16.

PMID: 16469877 PMC: 1895788. DOI: 10.1182/blood-2005-06-2216.

AKT induces erythroid-cell maturation of JAK2-deficient fetal liver progenitor cells and is required for Epo regulation of erythroid-cell differentiation.

Ghaffari S, Kitidis C, Zhao W, Marinkovic D, Fleming M, Luo B Blood. 2005; 107(5):1888-91.

PMID: 16254141 PMC: 1895702. DOI: 10.1182/blood-2005-06-2304.

Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway.

Zhao W, Kitidis C, Fleming M, Lodish H, Ghaffari S Blood. 2005; 107(3):907-15.

PMID: 16204311 PMC: 1895894. DOI: 10.1182/blood-2005-06-2516.

SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system.

Schiemann B, Neil J, Schiemann W Mol Biol Cell. 2003; 14(10):3977-88.

PMID: 14517312 PMC: 206993. DOI: 10.1091/mbc.e03-01-0001.

References

Issaad C, Vainchenker W . Growth of erythroid colonies in chronic myelogenous leukemia is independent of erythropoietin only in the presence of steel factor. Blood. 1994; 84(10):3447-56. View

Shtivelman E, Lifshitz B, Gale R, Canaani E . Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature. 1985; 315(6020):550-4. DOI: 10.1038/315550a0. View

Goldsmith M, Mikami A, You Y, Liu K, Thomas L, Pharr P . Absence of cytokine receptor-dependent specificity in red blood cell differentiation in vivo. Proc Natl Acad Sci U S A. 1998; 95(12):7006-11. PMC: 22719. DOI: 10.1073/pnas.95.12.7006. View

Daley G, Van Etten R, Baltimore D . Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science. 1990; 247(4944):824-30. DOI: 10.1126/science.2406902. View

Messerschmitt A, Dunant N, Ballmer-Hofer K . DNA tumor viruses and Src family tyrosine kinases, an intimate relationship. Virology. 1997; 227(2):271-80. DOI: 10.1006/viro.1996.8316. View

McWhirter J, Galasso D, Wang J . A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Mol Cell Biol. 1993; 13(12):7587-95. PMC: 364830. DOI: 10.1128/mcb.13.12.7587-7595.1993. View

Lansdorp P, Dragowska W . Long-term erythropoiesis from constant numbers of CD34+ cells in serum-free cultures initiated with highly purified progenitor cells from human bone marrow. J Exp Med. 1992; 175(6):1501-9. PMC: 2119250. DOI: 10.1084/jem.175.6.1501. View

Carlesso N, Frank D, Griffin J . Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J Exp Med. 1996; 183(3):811-20. PMC: 2192351. DOI: 10.1084/jem.183.3.811. View

Gishizky M, Cortez D, Pendergast A . Mutant forms of growth factor-binding protein-2 reverse BCR-ABL-induced transformation. Proc Natl Acad Sci U S A. 1995; 92(24):10889-93. PMC: 40536. DOI: 10.1073/pnas.92.24.10889. View

10.

Hawley T, Sabourin L, Hawley R . Comparative analysis of retroviral vector expression in mouse embryonal carcinoma cells. Plasmid. 1989; 22(2):120-31. DOI: 10.1016/0147-619x(89)90021-8. View

11.

Papayannopoulou T, Brice M, Blau C . Kit ligand in synergy with interleukin-3 amplifies the erythropoietin-independent, globin-synthesizing progeny of normal human burst-forming units-erythroid in suspension cultures: physiologic implications. Blood. 1993; 81(2):299-310. View

12.

Teglund S, Mckay C, Schuetz E, Van Deursen J, Stravopodis D, Wang D . Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell. 1998; 93(5):841-50. DOI: 10.1016/s0092-8674(00)81444-0. View

13.

Ilaria Jr R, Van Etten R . P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J Biol Chem. 1996; 271(49):31704-10. DOI: 10.1074/jbc.271.49.31704. View

14.

McWhirter J, Wang J . Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins. Mol Cell Biol. 1991; 11(3):1553-65. PMC: 369443. DOI: 10.1128/mcb.11.3.1553-1565.1991. View

15.

Kabarowski J, Allen P, Wiedemann L . A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells. EMBO J. 1994; 13(24):5887-95. PMC: 395564. DOI: 10.1002/j.1460-2075.1994.tb06934.x. View

16.

Cortez D, Kadlec L, Pendergast A . Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis. Mol Cell Biol. 1995; 15(10):5531-41. PMC: 230804. DOI: 10.1128/MCB.15.10.5531. View

17.

Lugo T, Pendergast A, Muller A, Witte O . Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science. 1990; 247(4946):1079-82. DOI: 10.1126/science.2408149. View

18.

Heisterkamp N, Jenster G, Ten Hoeve J, Zovich D, Pattengale P, Groffen J . Acute leukaemia in bcr/abl transgenic mice. Nature. 1990; 344(6263):251-3. DOI: 10.1038/344251a0. View

19.

Eaves A, Eaves C . Abnormalities in the erythroid progenitor compartments in patients with chronic myelogenous leukemia (CML). Exp Hematol. 1979; 7 Suppl 5:65-75. View

20.

Nieborowska-Skorska M, Wasik M, Slupianek A, Salomoni P, Kitamura T, Calabretta B . Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis. J Exp Med. 1999; 189(8):1229-42. PMC: 2193033. DOI: 10.1084/jem.189.8.1229. View